About Cabaletta Bio
Cabaletta Bio is a company based in Radnor (United States) founded in 2017.. Cabaletta Bio has raised $88.26 million across 2 funding rounds from investors including University of Pennsylvania, Adage Capital Management and 5AM Ventures. The company has 161 employees as of December 31, 2024. Cabaletta Bio operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Biogen and Rhythm Pharmaceuticals, among others.
- Headquarter Radnor, United States
- Employees 161 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cabaletta Bio, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-115.86 M-71.21as on Dec 31, 2024
-
EBITDA
$-120.33 M-64.31as on Dec 31, 2024
-
Total Equity Funding
$88.26 M (USD)
in 2 rounds
-
Latest Funding Round
$50 M (USD), Series B
Jan 03, 2019
-
Investors
University of Pennsylvania
& 6 more
-
Employee Count
161
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cabaletta Bio
Cabaletta Bio is a publicly listed company on the NASDAQ with ticker symbol CABA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Cabaletta Bio
Cabaletta Bio has successfully raised a total of $88.26M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $50.0M
-
First Round
First Round
(07 Dec 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Series B - Cabaletta Bio | Valuation | Deerfield , Redmile Group | |
| Dec, 2018 | Amount | Series A - Cabaletta Bio | Valuation | 5AM Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cabaletta Bio
Cabaletta Bio has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Pennsylvania, Adage Capital Management and 5AM Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cabaletta Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cabaletta Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cabaletta Bio Comparisons
Competitors of Cabaletta Bio
Cabaletta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Biogen and Rhythm Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cabaletta Bio
Frequently Asked Questions about Cabaletta Bio
When was Cabaletta Bio founded?
Cabaletta Bio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Cabaletta Bio located?
Cabaletta Bio is headquartered in Radnor, United States. It is registered at Radnor, Pennsylvania, United States.
Is Cabaletta Bio a funded company?
Cabaletta Bio is a funded company, having raised a total of $88.26M across 2 funding rounds to date. The company's 1st funding round was a Series A of $38.26M, raised on Dec 07, 2018.
How many employees does Cabaletta Bio have?
As of Dec 31, 2024, the latest employee count at Cabaletta Bio is 161.
What does Cabaletta Bio do?
Founded in 2017 and based in Radnor, United States, focus is placed on biotechnology for autoimmune disorders. CAAR T cells are engineered using a CAR-T cell platform to selectively target and eliminate autoantibody-producing B cells. Operations center on advancing this technology through research and development, with applications aimed at B cell-mediated conditions in the immunology sector.
Who are the top competitors of Cabaletta Bio?
Cabaletta Bio's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Is Cabaletta Bio publicly traded?
Yes, Cabaletta Bio is publicly traded on NASDAQ under the ticker symbol CABA.
Who are Cabaletta Bio's investors?
Cabaletta Bio has 7 investors. Key investors include University of Pennsylvania, Adage Capital Management, 5AM Ventures, Deerfield, and Redmile Group.
What is Cabaletta Bio's ticker symbol?
The ticker symbol of Cabaletta Bio is CABA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.